LivingGLP1
Study S001525

Efficacy of Liraglutide vs. Sitagliptin vs. Insulin Glargine Per Day on Liver Fat When Combined With Metformin in T2DM Subjects With Non-alcoholic Fatty-liver Disease

Registration

Registration
NCT02147925
Acronym
LIGHT-ON
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
COMPLETED
Enrollment
75
Start
2014-08
Primary completion
2017-04
Lead sponsor
Sun Yat-sen University
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG:Liraglutide combined with metformin; DRUG:Insulin glargine combined with metformin; DRUG:Sitagliptin combined with metformin
Results posted
FALSE

Registered primary outcomes

  • Intrahepatic lipids (IHL) [26-week]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.